Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	127.37	128.03	393.64	595.08	7.23	-
Short-Term Investments	167.46	128.52	-	-	-	-
Cash & Short-Term Investments	294.83	256.55	393.64	595.08	7.23	-
Cash Growth	-2.88%	-34.83%	-33.85%	8134.15%	-	-
Other Receivables	46.99	39.15	26.72	16.81	2.93	-
Receivables	46.99	39.15	26.72	16.81	2.93	-
Prepaid Expenses	0.06	1.65	2.79	4.66	0.01	-
Other Current Assets	13.62	17.74	14.59	12.22	1	-
Total Current Assets	355.5	315.09	437.75	628.77	11.17	-
Property, Plant & Equipment	12.37	12.95	1.17	0.16	-	-
Long-Term Deferred Tax Assets	28.59	29.65	3.51	-	-	-
Other Long-Term Assets	2.38	2.55	1.88	0.7	0.55	-
Total Assets	398.85	360.25	444.31	629.64	11.72	-
Accounts Payable	5.32	11.82	13.84	8.07	1.03	-
Accrued Expenses	20.24	26.62	22.23	15.7	1.04	-
Short-Term Debt	-	-	-	-	5.63	-
Current Portion of Leases	0.55	0.51	-	-	-	-
Current Income Taxes Payable	-	0.11	1.58	0.77	-	-
Other Current Liabilities	0.64	0.33	0.69	0.1	0.92	-
Total Current Liabilities	26.76	39.39	38.34	24.64	8.62	-
Long-Term Debt	76.5	75.7	69.8	75.7	-	-
Long-Term Leases	8.6	8.89	-	-	-	-
Other Long-Term Liabilities	0.03	0.03	-	37.74	-	-
Total Liabilities	111.88	124	108.14	138.08	8.62	-
Common Stock	0.31	0.27	0.27	0.25	25.55	-
Additional Paid-In Capital	1,120	987.42	939.26	876.27	0.83	-
Retained Earnings	-834.81	-752.95	-601.86	-385.65	-23.85	-
Comprensive Income & Other	1.6	1.49	-1.5	0.69	0.57	-
Shareholders' Equity	286.97	236.24	336.17	491.55	3.1	-
Total Liabilities & Equity	398.85	360.25	444.31	629.64	11.72	-
Total Debt	85.65	85.09	69.8	75.7	5.63	-
Net Cash (Debt)	209.19	171.46	323.84	519.38	1.6	-
Net Cash Growth	-5.21%	-47.06%	-37.65%	32361.38%	-	-
Net Cash Per Share	2.07	1.78	3.47	6.91	0.11	-
Filing Date Shares Outstanding	113.31	100.31	94.96	94.02	15	-
Total Common Shares Outstanding	113.18	98.77	94.84	89.99	15	-
Working Capital	328.75	275.71	399.41	604.14	2.55	-
Book Value Per Share	2.54	2.39	3.54	5.46	0.21	-
Tangible Book Value	286.97	236.24	336.17	491.55	3.1	-
Tangible Book Value Per Share	2.54	2.39	3.54	5.46	0.21	-
Machinery	1.54	1.5	0.44	0.2	-	-
Construction In Progress	-	-	0.89	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.